ClinicalTrials.gg
CompletedNCT03386110CHPUpdated Aug 19, 2021Results posted

Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk

An interventional study of Couples Health Project (CHP) and Education in Risk Behavior, Drug Use and Sex, Anal, sponsored by Hunter College of City University of New York. Completed at 1 site in United States. Open to male participants aged 18 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-19.

Sponsored by Hunter College of City University of New York · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 29 Years
Sex
Male
01

Study summary

This project tests the feasibility, acceptability, and preliminary efficacy of the Couples Health Project (CHP). CHP is a brief (3-session) couples-based Motivational Interviewing intervention which addresses drug use and sexual HIV transmission risk among partnered HIV negative YMSM (ages 18-29). The proposed project includes a randomized controlled trial (RCT) involving 50 couples who are randomized to complete either the CHP intervention or an attention-matched education control condition.

Read the detailed description

This study aims to evaluate a couples-based intervention with an integrated focus on drug use and HIV prevention, including uptake of and adherence to PrEP. The investigators will recruit a sample of 50 couples (n = 100 individuals)

Recruitment occurs using a mix of in-person and Internet recruitment. Outreach workers will visit bars and events in the New York City area to recruit participants. Also, information on our project will be posted on social media sites (e.g.,Facebook, Grindr, Scruff). Interested individuals will complete a brief online screener to assess eligibility.

A telephone screener will be conducted with participants who are preliminarily eligible based upon online screener responses. Participants who are eligible based upon telephone screening responses will be sent two emails. The first contains a link for them to access the baseline online survey. The second email is for them to forward to their partner. It provides information which introduces the study to the recruited partner and a link to the baseline survey online. If participants indicate intimate partner violence (IPV) on the online baseline survey, participants will be rendered ineligible. Only the participant that indicated experiencing IPV will be given a list of local referrals to access IPV-related services.

An in-person baseline assessment appointment will be scheduled after both participants have completed the online survey. If participants come to the research site alone, they will need to reschedule the appointment when both partners can attend.

The in-person baseline assessment appointment consists of four components; written consenting, a computer-assisted self interview (CASI), a timeline follow back interview, and biological testing.

Written consent is obtained with each participant individually in separate rooms. Participants additionally complete a computer-assisted self interview (CASI) independently. After this, participants will independently complete a TFLB.

TLFB is a semi-structured interview to collect retrospective event-level data on drug use, sexual behavior and PrEP adherence (for those on PrEP) in the past 30 days. Participants complete the survey and TLFB independently in a different room, without their partner.

The final part of the in-person baseline assessment consists of biological testing for STI (gonorrhea \& chlamydia via urinalysis and rectal swabs), drug testing via 5-panel fingernail drug assay via finger or toe nail clippings. Drugs tested are 5 major drugs: Amphetamines, Cannabinoids, Cocaine, Opiates, and Phencyclidine (PCP).

After the baseline assessment, participants will be randomized to receive their first CHP or Education session, of which the first session will occur immediately following their baseline assessment. The study will employ a stratified randomization procedure using an algorithm via Qualtrics. Couples will be randomized using three couple-level criteria. Couples will be randomized based on relationship length difference (less than 2 years versus 2 or more), age difference (less than 3 years versus 3 or more), and racial difference (both white versus all others combinations). Each of the intervention arms consists of 3 sessions that occur once a week for three consecutive weeks.

For Session 3 of the experimental and control conditions, participants complete a Couples HIV Testing and Counseling (CHTC) session that involves a rapid HIV testing for couples. HIV testing is done via the Alere Determine HIV-1/2 Ag/Ab Combo blood test. The couple undergo HIV testing together and receive the results together.

All participants complete a 1-month, 3-month, and 6-month follow ups. Follow-up appointments are scheduled with each participant independently (not as a couple). For the 1 month follow up (post baseline assessment), participants will complete an online survey at home for which participants are instructed to take this survey independent from their partner. At the 3 month follow up (post baseline assessment), participants complete a survey with a TLFB and Fingernail specimen collection for drug use at the research office. At the 6 month follow up (post baseline assessment), participants complete a survey with a TLFB and biological specimen collection to test drug use via fingernail sample and Gonorrhea \& Chlamydia for STI testing (Urinalysis and Rectal swabs) at the research offices.

02

Conditions studied

  • Risk Behavior
  • Drug Use
  • Sex, Anal

Keywords

  • Couples
  • MSM
  • HIV
  • Drug Use
03

In context

Risk-Taking

136 studies on the registry are indexed under Risk-Taking; 18 are open to participants now.

This study's enrollment of 100 is below the median of 255 across 117 interventional studies indexed under Risk-Taking.

Browse Risk-Taking studies →

Lead sponsor

Hunter College of City University of New York is the lead sponsor of 36 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least one member of the couple must be 18 to 29 years of age
  • Both members assigned male gender at birth and currently identify as male
  • At least one member of the couple reports an -negative serostatus
  • Couple has been together for at least 3 months
  • The use of at least one of the following substances in the past 30 days (only one partner): marijuana, cocaine/crack, amphetamines, ecstasy, GHB, ketamine, nitrates, prescriptionn drug misuse
  • At least one member of the couple, in the past 30 days, had condomless anal sex (CAS) with a casual partner and/or CAS with a non-monogamous or serodiscordant main partner.
  • Both members must be able to communicate in English
  • Both members must reside in the NYC metro area

Exclusion criteria

Exclusion Criteria:

  • Either member of the couple reports IPV, which is defined as serious physical or sexual violence that occurs outside the context of consensual bondage or sado-masochistic sexual play, which results in concerns of safety.
  • Inconsistencies between information provided in the eligibility screener and the in-person meeting or any issues that might hinder participation. The couple may also be deemed ineligible if participant responses are sufficiently inconsistent to call into question the validity of their individual responses
  • The couple reports a sero-concordant -positive serostatus
  • Unstable, serious psychiatric symptoms (assessed at Baseline)
  • Currently suicidal/homicidal
  • Evidence of gross cognitive impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Couples Health Project (CHP)

    The CHP intervention is a three session intervention that occurs once a week for three weeks. The CHP intervention will be delivered by MI-trained mental health counselors. The CHP intervention is comprised of 3 sessions. 25 couples will be allocated to this arm.

    Behavioral: Couples Health Project (CHP)

  • Active comparator
    Education

    The Education intervention is a attention-matched control three-session intervention that occurs once a week for three weeks. The education intervention will be delivered by trained health educators. The education intervention is comprised of 3 sessions. 25 couples will be allocated to this arm.

    Behavioral: Education

Interventions

  • BehavioralCouples Health Project (CHP)

    The CHP intervention focuses on addresses drug use and HIV transmission risk by enhancing dyadic communication skills and motivation to work towards shared health goals. The last session of the CHP intervention consists of a Couples HIV Testing and Counseling (CHTC) session.

  • BehavioralEducation

    The Education intervention consists of a 3-session health education intervention that addresses sexual risk and substance use through a lecture and question and answer format with a male couple. Additionally, the last session of the education intervention consists of a Couples HIV Testing and Counseling (CHTC) session.

06

What researchers measure

Primary outcomes

  1. Illicit Drug Use

    The self-reported number of illicit drug use instances (not including marijuana) in the past 30 days

    Time frame: Baseline, 3-month follow-up; 6-month follow-up

  2. Number of HIV Transmission Risk Events

    The self-reported number of events of condomless anal sex (CAS) with casual partners in the past 30 days

    Time frame: 6 months

Secondary outcomes

  1. Marijuana Use

    The self-reported number of marijuana drug use instances in the past 30 days

    Time frame: 6 months

07

Results

Posted Aug 19, 2021
Limitations and caveats
This was a pilot study with modest sample size intended to test preliminary efficacy and provide effect size estimates necessary to plan a larger trial. Results warrant replication in research with larger sample size. The sample was recruited from a large urban center and may not be representative of the wider U.S. population of partnered sexual minority men. Due to COVID, the collection of follow-up STI specimen data was curtailed, diminishing our ability to test associations with this outcome.

Participant flow

We used an index participant approach to recruit couples. Online recruitment included advertisements on websites and geosocial networking apps for gay, bisexual, trans, and queer people seeking out sexual partners. Also, staff attended bars, nightclubs, and other social events for these populations in the NYC metro area to screen. Through June 2019, eligible index participants were contacted by phone to complete a study specific screener. This was converted to an online survey in July 2019.

Participant flow — Overall Study
MilestoneCouples Health Project (CHP)Education
Started5644
Completed4138
Not completed156

Outcome measures

PrimaryIllicit Drug Use

The self-reported number of illicit drug use instances (not including marijuana) in the past 30 days

Time frame:
Baseline, 3-month follow-up; 6-month follow-up
Reported as:
Mean · Days (in the past 30 days)
Illicit Drug Use
Days (in the past 30 days)Couples Health Project (CHP)Education
Use at Baseline3.36 ± 8.460.84 ± 2.34
Use at 3-month follow-up3.13 ± 8.410.73 ± 1.37
Use at 6-month follow-up1.17 ± 3.790.58 ± 1.24
Statistical analysis
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.08 · Risk ratio, log: 1.19 · 95% CI -0.15 to 2.54Model testing whether condition predicted illicit drug use at 3-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.25 · Risk ratio, log: 0.70 · 95% CI -0.49 to 1.89Model testing whether condition predicted illicit drug use at 6-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.007 · Risk ratio, log: 1.79 · 95% CI 0.49 to 3.09Three-way interaction model testing whether baseline use (actor and partner) moderated the effect of condition on illicit drug use at 3-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.71 · Risk ratio, log: -0.36 · 95% CI -2.26 to 1.53Three-way interaction model testing whether baseline use (actor and partner) moderated the effect of condition on illicit drug use at 6-months
PrimaryNumber of HIV Transmission Risk Events

The self-reported number of events of condomless anal sex (CAS) with casual partners in the past 30 days

Time frame:
6 months
Reported as:
Mean · Events in the past 30 days
Number of HIV Transmission Risk Events
Events in the past 30 daysCouples Health Project (CHP)Education
Events at Baseline1.68 ± 2.781.68 ± 2.34
Events at 3-month follow-up2.13 ± 3.611.49 ± 3.70
Events at 6-month follow-up0.88 ± 1.661.05 ± 1.82
Statistical analysis
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.36 · Risk ratio, log: 0.36 · 95% CI -0.65 to 1.37Model testing whether condition predicted CAS events at 3-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.63 · Risk ratio, log: -0.18 · 95% CI -1.15 to 0.78Model testing whether condition predicted CAS events at 6-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.42 · Risk ratio, log: -0.54 · 95% CI -1.85 to 0.77Three-way interaction model testing whether baseline rates of CAS (actor and partner) moderated the effect of condition on CAS events at 3-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.02 · Risk ratio, log: -1.70 · 95% CI -3.14 to -0.27Three-way interaction model testing whether baseline rates of CAS (actor and partner) moderated the effect of condition on CAS events at 6-months
SecondaryMarijuana Use

The self-reported number of marijuana drug use instances in the past 30 days

Time frame:
6 months
Reported as:
Mean · days out of 30
Marijuana Use
days out of 30Couples Health Project (CHP)Education
Use at Baseline9.61 ± 11.937.02 ± 10.24
Use at 3-month follow-up9.62 ± 11.835.95 ± 10.24
Use at 6-month follow-up10.00 ± 12.437.89 ± 11.75
Statistical analysis
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.15 · Risk ratio, log: 0.48 · 95% CI -0.18 to 1.44Model testing whether condition predicted marijuana use at 3-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.50 · Risk ratio, log: 0.24 · 95% CI -0.44 to 0.92Model testing whether condition predicted marijuana use at 6-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.910 · Risk ratio, log: -0.02 · 95% CI -0.34 to 0.31Three-way interaction model testing whether baseline use moderated the effect of condition on marijuana use at 3-months
  • Couples Health Project (CHP) vs Education · Mixed Models Analysis · p = 0.11 · Risk ratio, log: 0.34 · 95% CI -0.07 to 0.75

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Couples Health Project (CHP)0/56 (0%)0/56 (0%)0/56 (0%)
Education0/44 (0%)0/44 (0%)0/44 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Couples Health Project (CHP)EducationTotal
<=18 years000
Between 18 and 65 years5644100
>=65 years000
Age, Continuous
Age, Continuous(years)Couples Health Project (CHP)EducationTotal
Mean28.7 ± 6.1728.05 ± 6.1028.41 ± 6.12
Sex: Female, Male
Sex: Female, Male(Participants)Couples Health Project (CHP)EducationTotal
Female000
Male5644100
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Couples Health Project (CHP)EducationTotal
Race & Ethnicity — White/European332558
Race & Ethnicity — Black/African American5611
Race & Ethnicity — Latino111122
Race & Ethnicity — Other729
Region of Enrollment
Region of Enrollment(participants)Couples Health Project (CHP)EducationTotal
United States5644100
HIV Status
HIV Status(Participants)Couples Health Project (CHP)EducationTotal
HIV-negative513990
HIV-positive5510
08

Study locations

1 site
  • Center for HIV Educational Studies and Training
    New York, New York 10018, United States
09

References and documents

Publications

  • Parsons JT, Lelutiu-Weinberger C, Botsko M, Golub SA. A randomized controlled trial utilizing motivational interviewing to reduce HIV risk and drug use in young gay and bisexual men. J Consult Clin Psychol. 2014 Feb;82(1):9-18. doi: 10.1037/a0035311. Epub 2013 Dec 23. PubMed 24364800 ↗
  • Starks TJ, Adebayo T, Kyre KD, Millar BM, Stratton MJ Jr, Gandhi M, Ingersoll KS. Pilot Randomized Controlled Trial of Motivational Interviewing with Sexual Minority Male Couples to Reduce Drug Use and Sexual Risk: The Couples Health Project. AIDS Behav. 2022 Feb;26(2):310-327. doi: 10.1007/s10461-021-03384-9. Epub 2021 Jul 23. PubMed 34297275 ↗
  • Starks TJ, Feldstein Ewing SW, Lovejoy T, Gurung S, Cain D, Fan CA, Naar S, Parsons JT. Adolescent Male Couples-Based HIV Testing Intervention (We Test): Protocol for a Type 1, Hybrid Implementation-Effectiveness Trial. JMIR Res Protoc. 2019 Jun 7;8(6):e11186. doi: 10.2196/11186. PubMed 31199341 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — A databank may be used to share data consistent with the NIH resource sharing agreement. The requester will contact the PI of the study and the PI will contact the CUNY Office for Research Compliance per university guidelines for data sharing.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Sep 2020, 30 months.

Results were first posted in Aug 2021, 11 months after primary completion.

Of 65 non-industry interventional studies with no phase under Risk-Taking, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 48. This study's 30 months is close to that.

Counting every sponsor, half of 68 studies reached it within 28 months; a quarter within 7 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 21, 2017
First posted
Dec 29, 2017
StartActual
Mar 6, 2018
Primary completionActual
Sep 14, 2020
CompletionActual
Sep 14, 2020
Results first posted
Aug 19, 2021
Last update
Aug 19, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03386110
Lead sponsor
Hunter College of City University of New York
Responsible party
Tyrel Starks (Associate Professor of Psychology, Hunter College of City University of New York) — Principal investigator
First posted
Dec 29, 2017
Start date
Mar 6, 2018
Primary completion
Sep 14, 2020
Completion
Sep 14, 2020
Results posted
Aug 19, 2021
Last update
Aug 19, 2021

Study contacts

Tyrel J Starks, PhD
principal investigator · Hunter College of City University of New York

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion